StonvexLoading…
StonvexStonvexStonvexCore line items from CNX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.24B | $1.27B | $3.43B | $1.26B |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $633.16M | $-90.49M | $1.72B | $-142.08M |
EPS (Diluted) | $3.98 | $-0.60 | $8.99 | $-0.75 |
Total Assets | $9.09B | $8.51B | $8.63B | $8.52B |
Total Liabilities | $4.76B | $4.41B | $4.27B | $5.57B |
Cash & Equivalents | $779.00K | $17.20M | $443.00K | $21.32M |
Free Cash Flow OCF − CapEx | $533.97M | $275.45M | $135.18M | $669.26M |
Shares Outstanding | 142.59M | 148.88M | 154.38M | 170.84M |